Foresee Pharmaceuticals Co., Ltd. (TPEX:6576)

Foresee Pharmaceuticals Revenue

Foresee Pharmaceuticals had revenue of 181.65M TWD in the quarter ending June 30, 2026, with 62.70% growth. This brings the company's total for the last twelve months to 471.13M, up 6.41% year-over-year. In the year 2025, Foresee Pharmaceuticals had annual revenue of 431.27M with 3.01% growth. That makes Foresee Pharmaceuticals the 35,645th largest company in the world by revenue and 1,853rd in Taiwan.

• Revenue (ttm): 471.13M
• Revenue Growth: +6.41%
• P/S Ratio: 24.04
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 11.33B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• United States 272.75M 63.2%
• China 112.42M 26.1%
• Europe 46.10M 10.7%

Fiscal year ended Dec 31, 2025 See the full Foresee Pharmaceuticals breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	431.27M	12.59M	3.01%
Dec 31, 2024	418.69M	223.65M	114.67%
Dec 31, 2023	195.04M	-106.47M	-35.31%
Dec 31, 2022	301.51M	75.48M	33.39%
Dec 31, 2021	226.03M	-4.41M	-1.91%

Data Source: S&P Global Market Intelligence Last updated: Aug 14, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error